Sarah Marking is the Co-Founder and Chief Strategy Officer at Sanova. Sarah has broad experience serving pharma, medical device, and consumer products industries, with a focus on integrating science, quality processes, and business goals in a regulated environment. She has a proven ability to develop resilient, cross-functional teams and champion complex projects across diverse groups of stakeholders.
Sarah works closely with clients to plan and submit premarket tobacco product applications (PMTAs) and modified risk tobacco product applications (MRTPAs)across various nicotine product categories, including novel, emerging delivery systems. She combines her extensive industry experience, scientific expertise ,and business acumen to navigate the rapidly evolving regulatory landscape and provide practical solutions to regulatory challenges. Sarah supports regulatory strategy across all scientific areas including product design and development, manufacturing, and nonclinical and clinical study programs.
She specializes in helping clients create and navigate multi-product regulatory strategies and product line extensions. These strategies leverage existing scientific evidence through use of supplemental PMTAs (sPMTAs) and tobacco product master files (TPMFs) to minimize regulatory costs and timelines. She also supports preparation for Tobacco ProductsScientific Advisory Committee (TPSAC) meetings.
